title: Is an FDA alert harming patients?
authors.affiliation: Department of Adult Neurology, Kaiser Permanente, Portland, Oregon, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Schuman
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008297:Male; D008881:Migraine Disorders / Q000188:drug therapy*; D012307:Risk Factors; D020230:Serotonin Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D014363:Tryptamines / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors; D014363:Tryptamines